Indian News


pharmaup-july22.jpg The following are some of today's top gainers in the healthcare sector.

pharma-042117_22jul19.jpg Today's Daily Dose brings you news about the FDA decisions related to Biohaven's NURTEC and Celgene's OTEZLA; interim data from Marker's MultiTAA T cell therapy trial and Takeda's phase III trial results of subcutaneous formulation of Vedolizumab in Crohn's disease, among others.

biotechipo-july19.jpg As another week comes to a close, it is time to take a look at the U.S. healthcare IPOs scheduled for the week ahead.

ussboxer-july19.jpg Iran refuted US claim that their warship has destroyed an Iranian drone above the Strait of Hormuz on Thursday, as it came dangerously close to the vessel. President Donald Trump confirmed the incident at a briefing at the White House, on the sidelines of a flag ceremony with Dutch Prime Minister Mark Rutte. He said USS Boxer, a navy amphibious assault ship, shot the drone down when it closed i

netflix-july19.jpg Streaming giant Netflix confirmed that it will launch a mobile-only streaming plan starting in India, which will be less expensive than its current plans. With the move, the company aims to attract a larger crowd in one of its major market. The news comes at a time when the Unites States recorded declining subscribers for the video streaming service in its second quarter.

pharmacy-040318_19jul19.jpg Today's Daily Dose brings you news about UnitedHealth's rosy outlook; MyoKardia's upcoming milestone in 2020; Atara's public offering, and collaboration between Bayer, Bristol-Myers Squibb (BMY) and Ono Pharmaceutical.

pharmadown-july18.jpg The following are some of the pharma/biotech stocks that posted the biggest percentage decline on Thursday.

pharmaup-july18.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharma-032417_18jul19.jpg Today's Daily Dose brings you news about FDA approval of Merck's antibiotic; Durect's upcoming regulatory catalyst; stock offering of Amarin and bankruptcy filing of Airxpanders.

Follow RTT